Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration

1 Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama; 2 Institute for Biomedical Engineering, Consolidated Research Institute for Advanced Science and Medical Care, Waseda University, Tokyo; 3 Department of Cardiovascular Medicine, Tokyo University Scho...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology. Heart and circulatory physiology Vol. 295; no. 4; pp. H1547 - H1555
Main Authors Yokoyama, Utako, Minamisawa, Susumu, Quan, Hong, Akaike, Toru, Jin, Meihua, Otsu, Koji, Ulucan, Coskun, Wang, Xu, Baljinnyam, Erdenechimeg, Takaoka, Minoru, Sata, Masataka, Ishikawa, Yoshihiro
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.10.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:1 Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama; 2 Institute for Biomedical Engineering, Consolidated Research Institute for Advanced Science and Medical Care, Waseda University, Tokyo; 3 Department of Cardiovascular Medicine, Tokyo University School of Medicine, Tokyo, Japan; and 4 Cardiovascular Research Institute, Departments of Cell Biology and Molecular Medicine and Medicine (Cardiology), New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey Submitted 9 November 2007 ; accepted in final form 4 August 2008 Vascular remodeling after mechanoinjury largely depends on the migration of smooth muscle cells, an initial key step to wound healing. However, the role of the second messenger system, in particular, the cAMP signal, in regulating such remodeling remains controversial. Exchange protein activated by cAMP (Epac) has been identified as a new target molecule of the cAMP signal, which is independent from PKA. We thus examined whether Epac plays a distinct role from PKA in vascular remodeling. To examine the role of Epac and PKA in migration, we used primary culture smooth muscle cells from both the fetal and adult rat aorta. A cAMP analog selective to PKA, 8-(4-parachlorophenylthio)-cAMP (pCPT-cAMP), decreased cell migration, whereas an Epac-selective analog, 8-pCPT-2'- O -Me-cAMP, enhanced migration. Adenovirus-mediated gene transfer of PKA decreased cell migration, whereas that of Epac1 significantly enhanced cell migration. Striking morphological differences were observed between pCPT-cAMP- and 8-pCPT-2'- O -Me-cAMP-treated aortic smooth muscle cells. Furthermore, overexpression of Epac1 enhanced the development of neointimal formation in fetal rat aortic tissues in organ culture. When the mouse femoral artery was injured mechanically in vivo, we found that the expression of Epac1 was upregulated in vascular smooth muscle cells, whereas that of PKA was downregulated with the progress of neointimal thickening. Our findings suggest that Epac1, in opposition to PKA, increases vascular smooth muscle cell migration. Epac may thus play an important role in advancing vascular remodeling and restenosis upon vascular injury. cAMP; protein kinase A; vascular remodeling; exchange protein activated by cAMP Address for reprint requests and other correspondence: Y. Ishikawa or S. Minamisawa, Cardiovascular Research Institute, Yokohama City Univ. Graduate School of Medicine, 3-9 Fukuura Kanazawa-ku, Yokohama 236-0004, Japan (e-mail: yishikaw{at}med.yokohama-cu.ac.jp )
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Address for reprint requests and other correspondence: Y. Ishikawa or S. Minamisawa, Cardiovascular Research Institute, Yokohama City Univ. Graduate School of Medicine, 3-9 Fukuura Kanazawa-ku, Yokohama 236-0004, Japan (e-mail: yishikaw@med.yokohama-cu.ac.jp or sminamis@med.yokohama-cu.ac.jp)
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.01317.2007